Course Catalog
Browse our full catalog of continuing education courses and events
Browse Courses & Events
Retina Resource
Tumor Board: Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum
Tina Cascone, MD, PhD; Christina Baik, MD, MPH; David Planchard, MD, PhD
A New Era of Targeted Therapy for Advanced NSCLC: Exploring Future Directions for Bispecific Antibodies and ADCs
Sandip Patel, MD, FASCO; Myung-Ju Ahn, MD; Giannis Mountzios, MD, MSc, PhD; Zofia Piotrowska, MD, MH...
Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies
Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO
Community Practice Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy–Strategies for the Multidisciplinary Team
Yana G. Najjar, MD; Sapna Patel, MD
Pathways to Progress: RAS in GI Cancers (Spotlight CE Session)
John H. Strickler, MD; Tanios S. Bekaii-Saab, MD; Bassel F. El-Rayes, MD; Ignacio Garrido-Laguna, MD...
Developing a Long-Term Monitoring Plan to Assess Prostate Cancer Risk
Jason M. Hafron, MD
Community Practice Connections™: Distinguishing Precision Pathways for c-Met and MET Alterations in NSCLC
Jonathan Goldman, MD; Erminia Massarelli, MD, PhD, MS; Jorge J. Nieva, MD; Ignacio I. Wistuba, MD
Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care
Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, ...
Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified
Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO
Radioligand Therapy 101: The Science Behind the Strategy
Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO
BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer
Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, ...
Imaging Matters: Decoding PSMA PET for Better Decision-Making
Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO
Navigating Treatment Gaps in SCLC: Relapse, Resistance, and Need for New Options
Rahul Gosain, MD, MBA; Rohit Gosain, MD; Giannis Mountzios ΜD, PhD
Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease
Mark R. Barakat, MD, FASRS; David Eichenbaum, MD, FASRS
PER Resource Center: Integrating Novel Approaches in TNBC – New Avenues for TROP2-Targeting ADCs and Beyond – Nursing
Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Virginia Kaklamani, MD, DSc; Filipa Lynce, MD;...
Collaborating Across the Continuum™: The Pediatrician’s Vital Role in Multidisciplinary Management of Pediatric PAH
Jean M. Elwing, MD, FCCP; Russel Hirsch, MD; John F. Morehous, MD
Expert Roundtable and Panel Discussions: Current and Future Landscape of TNBC
Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Tiffany A. Traina, MD, FASCO
Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP
Ramiro Maldonado, MD; Rebecca Nelson, MS, CGC; Robert A. Sisk, MD, FACS, FASRS
Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment
Dilsher Dhoot, MD, FASRS; Jordana G. Fein, MD, MS; Deep Parikh, MD; Xiao-Yi (Ellie) Zhou, MD
Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient
Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP
The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice
Dante Pieramici, MD, FASRS; Dean Eliott, MD; Robin A. Vora, MD; Charles C. Wykoff, MD, PhD, FASRS
A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management
David Almeida, MD, PhD, MBA; Margaret A. Chang, MD, MS; Arshad M. Khanani, MD, MA, FASRS; Jessica Ra...
Practical Considerations and Future Directions for New Treatment Strategies in SCLC
Rahul Gosain, MD, MBA; Rohit Gosain, MD; Misty D. Shields, MD, PhD
SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia
Gus Alva, MD, DFAPA; Ilan Melnick, MD
Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management
Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD
SoCal Psych 2025: Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder
Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C
Show Me the Data®: New and Emerging Roles for Oral SERD Therapy in the Treatment of ER+/HER2– Breast Cancer
Ana C. Garrido-Castro, MD; Pedram Razavi, MD, PhD
2nd Annual CNS Oncology Conference: Advances in Primary and Metastatic Brain Tumors
January 28, 2027
Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 68th ASH Annual Meeting
April 10-11, 2027
Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment
Jason Hafron, MD; Aaron D. Berger, MD; Arpeet Shah, MD
